These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 18309713)

  • 21. Localized and persistent erythema nodosum leprosum - a rare variant?
    Prabhu S; Rao R; Sripathi H; Rao L; Singh R
    Dermatol Online J; 2008 Mar; 14(3):16. PubMed ID: 18627717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of thalidomide in the management of erythema nodosum leprosum.
    Walker SL; Waters MF; Lockwood DN
    Lepr Rev; 2007 Sep; 78(3):197-215. PubMed ID: 18035771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunotherapy with Mycobacterium w vaccine decreases the incidence and severity of type 2 (ENL) reactions.
    Zaheer SA; Misra RS; Sharma AK; Beena KR; Kar HK; Mukherjee A; Mukherjee R; Walia R; Talwar GP
    Lepr Rev; 1993 Mar; 64(1):7-14. PubMed ID: 8464320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinico-pathological features of erythema nodosum leprosum: A case-control study at ALERT hospital, Ethiopia.
    Negera E; Walker SL; Girma S; Doni SN; Tsegaye D; Lambert SM; Idriss MH; Tsegay Y; Dockrell HM; Aseffa A; Lockwood DN
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006011. PubMed ID: 29028793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A fatal case of erythema necroticans.
    Davis SV; Shenoi SD; Balachandran C; Pai SB
    Indian J Lepr; 2002; 74(2):145-9. PubMed ID: 12708733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of circulating IgG subclasses against lipoarabinomannan in the leprosy spectrum and reactions.
    Beuria MK; Mohanty KK; Katoch K; Sengupta U
    Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4):422-8. PubMed ID: 10700917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoantibodies in lepromatous leprosy.
    Ochieng NA; Bwire MS; Orege PA; Nyawalo JO; K'Omollo JW
    Afr J Health Sci; 1994 May; 1(2):79-83. PubMed ID: 12153365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pulsed corticosteroid therapy in patients with chronic recurrent ENL: a pilot study.
    Girdhar A; Chakma JK; Girdhar BK
    Indian J Lepr; 2002; 74(3):233-6. PubMed ID: 12708702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Group specific component (Gc) in erythema nodosum leprosum (ENL).
    Ghei SK; Agrewala JN; Sengupta U; Sudhakar KS
    Indian J Lepr; 1993; 65(3):323-5. PubMed ID: 8283068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T-cell regulation in Erythema Nodosum Leprosum.
    Negera E; Walker SL; Bobosha K; Howe R; Aseffa A; Dockrell HM; Lockwood DN
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006001. PubMed ID: 28991896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral zinc therapy in recurrent erythema nodosum leprosum: a clinical study.
    Mahajan PM; Jadhav VH; Patki AH; Jogaikar DG; Mehta JM
    Indian J Lepr; 1994; 66(1):51-7. PubMed ID: 7983392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibrinolytic phenomenon in leprosy.
    Jadhav VH; Jadhav MV; Sapatnekar SM; Joshi PB
    Indian J Lepr; 1990; 62(2):208-14. PubMed ID: 2212736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erythema nodosum leprosum in Nepal: a retrospective study of clinical features and response to treatment with prednisolone or thalidomide.
    Feuth M; Brandsma JW; Faber WR; Bhattarai B; Feuth T; Anderson AM
    Lepr Rev; 2008 Sep; 79(3):254-69. PubMed ID: 19009975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pentoxifylline decreases in vivo and in vitro tumour necrosis factor-alpha (TNF-alpha) production in lepromatous leprosy patients with erythema nodosum leprosum (ENL).
    Sampaio EP; Moraes MO; Nery JA; Santos AR; Matos HC; Sarno EN
    Clin Exp Immunol; 1998 Feb; 111(2):300-8. PubMed ID: 9486396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methotrexate in resistant ENL.
    Kar BR; Babu R
    Int J Lepr Other Mycobact Dis; 2004 Dec; 72(4):480-2. PubMed ID: 15755203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum immunoglobulins an autoantibodies during and after erythema nodosum leprosum (ENL).
    Sharma VK; Saha K; Sehgal VN
    Int J Lepr Other Mycobact Dis; 1982 Jun; 50(2):159-63. PubMed ID: 6811448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between TNF production, increase of plasma C-reactive protein level and suppression of T lymphocyte response to concanavalin A during erythema nodosum leprosum.
    Foss NT; de Oliveira EB; Silva CL
    Int J Lepr Other Mycobact Dis; 1993 Jun; 61(2):218-26. PubMed ID: 8371031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alpha-1-antitrypsin in leprosy.
    Deshpande SV; Zawar PB; Chawhan RN; Sengupta SR; Mehta MC
    Indian J Lepr; 1985; 57(4):767-72. PubMed ID: 3938987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does pentoxifylline find a place in the armementarium of leprologists in type II reaction?
    Chatterjee M; Jaiswal AK
    Indian J Lepr; 2002; 74(4):329-34. PubMed ID: 12624981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased activated memory B-cells in the peripheral blood of patients with erythema nodosum leprosum reactions.
    Negera E; Walker SL; Bekele Y; Dockrell HM; Lockwood DN
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006121. PubMed ID: 29253897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.